Authors: PASSALI D CALEARO C CONTICELLO S ANTONELLI A ARSALAN E BARBIERI A BERNARDESCHI P BOCCUZZI V CASONI M COCCO M COLLETTI V CROCE G DANNA M DEBENEDETTO M DEGREGORIO S DIGREGORIO E DINASSO F FABBRI F FELISATI D STORCHI OF GALLI S GIACCAI F GRANDE F LAUDADIO P LUVARA A MARCATO D MARCHIORI G MARCUCCI L MESSINA D MIANI P NAPOLITANO S PANTALENA V PASTORE A PELLEGRINO S PERAZZITTI L PINTUCCI JP PRECERUTTI G PUXEDDU P SAVOCA A SENSINI I SEVERINI S SPERATI G SPINAZZOLA G TASSINI G ZERILLO G

Citation: D. Passali et al., PIDOTIMOD IN THE MANAGEMENT OF RECURRENT PHARYNGOTONSILLAR INFECTIONSIN CHILDHOOD, Arzneimittel-Forschung, 44-2(12A), 1994, pp. 1511-1516

Authors: GEBBIA V AGOSTARA B CALLARI A ZERILLO G RESTIVO G SPECIALE R CUPIDO G INGRIA F SPATAFORA G FAZIO L GALLINA S ZERILLO F LOBUE P TERMINI G LOMBARDO F VALENZA R TESTA A CANNATA G CIMINO A GEBBIA N

Citation: V. Gebbia et al., HEAD AND NECK-CARCINOMA WITH DISTANT METASTASES - A RETROSPECTIVE ANALYSIS OF 44 CASES TREATED WITH CISPLATIN-BASED CHEMOTHERAPEUTIC REGIMENS, Anticancer research, 13(4), 1993, pp. 1129-1131

Authors: GEBBIA V TESTA A VALENZA R ZERILLO G RESTIVO S CUPIDO G INGRIA F BARBACCIA C SPADAFORA G CANNATA G GEBBIA N

Citation: V. Gebbia et al., A PHASE-II STUDY OF LEVOFOLINIC ACID AND 5-FLUOROURACIL PLUS CISPLATIN IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Oncology, 50(6), 1993, pp. 490-494

Authors: GEBBIA V ZERILLO G RESTIVO G SPECIALE R CUPIDO G LOBUE P INGRIA F GALLINA S SPATAFORA G TESTA A CANNATA G CIMINO A GEBBIA N

Citation: V. Gebbia et al., CHEMOTHERAPEUTIC TREATMENT OF RECURRENT AND OR METASTATIC NASOPHARYNGEAL CARCINOMA - A RETROSPECTIVE ANALYSIS OF 40 CASES, British Journal of Cancer, 68(1), 1993, pp. 191-194

Authors: GEBBIA V VALENZA R TESTA A ZERILLO G RESTIVO S CUPIDO G INGRIA F SPADAFORA G BARBACCIA C CANNATA G CIPOLLA C GEBBIA N

Citation: V. Gebbia et al., WEEKLY 5-FLUOROURACIL AND FOLINIC ACID PLUS ESCALATING DOSES OF CISPLATIN WITH GLUTATHIONE PROTECTION IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER, Medical oncology and tumor pharmacotherapy, 9(4), 1992, pp. 165-168